RxDoctor Payments Data

Dana Garner, NP

Adult Health · Glendale, AZNPI 1285905315

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Organogenesis Inc. at 33.5% of the total.

$2,299in general payments, 2019–2025

Across 92 payments — averaging $24.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$771
  • AbbVie$297
  • Surgenex LLC$209
  • Integra Lifesciences Corporation$170
  • Novo Nordisk$160
  • Mimedx Group, Inc.$111
  • plus $583 from 17 others

What the payments were for

  • Food & beverage$2,299100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,299 in reported general payments places this provider in the 80th percentile of 314 adult health providers in Arizona.

See all adult health providers in Arizona

Medicare billing

Part B allowed, 2024
$77,111
Medicare patients
78
Services billed
913

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.11$4,422
Gentamicin Sulfate27$1,142
Doxycycline Hyclate33$501
Ciprofloxacin Hcl11$123
Mupirocin11$99
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$76

Paid to pharmacies, not to this prescriber.

Other adult health in Glendale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →